Selected research
Market Structure
Global Adeno Associated Virus Production Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Adeno Associated Virus Production market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Adeno Associated Virus Production is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Adeno Associated Virus Production include Biovian, Charles River, Lonza, Merck Group, OriGene, Sigma-Aldrich, SIRION Biotech, Thermo Fisher Scientific and Vigene Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Adeno Associated Virus Production market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Adeno Associated Virus Production and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Adeno Associated Virus Production revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Adeno Associated Virus Production market size, projected growth trends, production technologies, key applications, and end-use industries.
Adeno Associated Virus Production Segment by Company
Biovian
Charles River
Lonza
Merck Group
OriGene
Sigma-Aldrich
SIRION Biotech
Thermo Fisher Scientific
Vigene Biosciences
Yeasen Aav
Adeno Associated Virus Production Segment by Type
Large-Scale Production
Customized Production
Adeno Associated Virus Production Segment by Application
Vaccine Production
Gene Therapy
Others
Adeno Associated Virus Production Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adeno Associated Virus Production market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adeno Associated Virus Production and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adeno Associated Virus Production.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Adeno Associated Virus Production in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Adeno Associated Virus Production industry.
Chapter 3: Detailed analysis of Adeno Associated Virus Production companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adeno Associated Virus Productionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Large-Scale Production
- Customized Production
Applications
- Vaccine Production
- Gene Therapy
- Others
Companies covered
- Biovian
- Charles River
- Lonza
- Merck Group
- OriGene
- Sigma-Aldrich
- SIRION Biotech
- Thermo Fisher Scientific
- Vigene Biosciences
- Yeasen Aav
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Adeno Associated Virus Production Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Large-Scale Production
- 1.2.3 Customized Production
- 1.3 Market Analysis by Application
- 1.3.1 Global Adeno Associated Virus Production Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Vaccine Production
- 1.3.3 Gene Therapy
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Adeno Associated Virus Production Growth Trends by Region
- 1.5.1 Global Adeno Associated Virus Production Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Adeno Associated Virus Production Market Size by Region (2021-2026)
- 1.5.3 Adeno Associated Virus Production Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Adeno Associated Virus Production Market Dynamics
- 2.1 Adeno Associated Virus Production Industry Trends
- 2.2 Adeno Associated Virus Production Industry Drivers
- 2.3 Adeno Associated Virus Production Industry Opportunities and Challenges
- 2.4 Adeno Associated Virus Production Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Adeno Associated Virus Production Revenue by Company (2021-2026)
- 3.2 Global Adeno Associated Virus Production Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Adeno Associated Virus Production Key Company Head office and Area Served
- 3.4 Global Adeno Associated Virus Production Company, Product Type & Application
- 3.5 Global Adeno Associated Virus Production Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Adeno Associated Virus Production Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Adeno Associated Virus Production Players Market Share by Revenue in 2025
- 3.6.3 2025 Adeno Associated Virus Production Tier 1, Tier 2, and Tier 3
4 Adeno Associated Virus Production Market by Type
- 4.1 Global Adeno Associated Virus Production Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Adeno Associated Virus Production Market Size by Type (2021-2032)
- 4.3 Global Adeno Associated Virus Production Market Size Share by Type (2021-2032)
5 Adeno Associated Virus Production Market by Application
- 5.1 Global Adeno Associated Virus Production Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Adeno Associated Virus Production Market Size by Application (2021-2032)
- 5.3 Global Adeno Associated Virus Production Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Biovian
- 6.1.1 Biovian Company Information
- 6.1.2 Biovian Business Overview
- 6.1.3 Biovian Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Biovian Adeno Associated Virus Production Product Portfolio
- 6.1.5 Biovian Recent Developments
- 6.2 Charles River
- 6.2.1 Charles River Company Information
- 6.2.2 Charles River Business Overview
- 6.2.3 Charles River Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Charles River Adeno Associated Virus Production Product Portfolio
- 6.2.5 Charles River Recent Developments
- 6.3 Lonza
- 6.3.1 Lonza Company Information
- 6.3.2 Lonza Business Overview
- 6.3.3 Lonza Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Lonza Adeno Associated Virus Production Product Portfolio
- 6.3.5 Lonza Recent Developments
- 6.4 Merck Group
- 6.4.1 Merck Group Company Information
- 6.4.2 Merck Group Business Overview
- 6.4.3 Merck Group Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Merck Group Adeno Associated Virus Production Product Portfolio
- 6.4.5 Merck Group Recent Developments
- 6.5 OriGene
- 6.5.1 OriGene Company Information
- 6.5.2 OriGene Business Overview
- 6.5.3 OriGene Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 OriGene Adeno Associated Virus Production Product Portfolio
- 6.5.5 OriGene Recent Developments
- 6.6 Sigma-Aldrich
- 6.6.1 Sigma-Aldrich Company Information
- 6.6.2 Sigma-Aldrich Business Overview
- 6.6.3 Sigma-Aldrich Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Sigma-Aldrich Adeno Associated Virus Production Product Portfolio
- 6.6.5 Sigma-Aldrich Recent Developments
- 6.7 SIRION Biotech
- 6.7.1 SIRION Biotech Company Information
- 6.7.2 SIRION Biotech Business Overview
- 6.7.3 SIRION Biotech Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 SIRION Biotech Adeno Associated Virus Production Product Portfolio
- 6.7.5 SIRION Biotech Recent Developments
- 6.8 Thermo Fisher Scientific
- 6.8.1 Thermo Fisher Scientific Company Information
- 6.8.2 Thermo Fisher Scientific Business Overview
- 6.8.3 Thermo Fisher Scientific Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Thermo Fisher Scientific Adeno Associated Virus Production Product Portfolio
- 6.8.5 Thermo Fisher Scientific Recent Developments
- 6.9 Vigene Biosciences
- 6.9.1 Vigene Biosciences Company Information
- 6.9.2 Vigene Biosciences Business Overview
- 6.9.3 Vigene Biosciences Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Vigene Biosciences Adeno Associated Virus Production Product Portfolio
- 6.9.5 Vigene Biosciences Recent Developments
- 6.10 Yeasen Aav
- 6.10.1 Yeasen Aav Company Information
- 6.10.2 Yeasen Aav Business Overview
- 6.10.3 Yeasen Aav Adeno Associated Virus Production Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Yeasen Aav Adeno Associated Virus Production Product Portfolio
- 6.10.5 Yeasen Aav Recent Developments
7 North America
- 7.1 North America Adeno Associated Virus Production Market Size (2021-2032)
- 7.2 North America Adeno Associated Virus Production Market Size by Type
- 7.2.1 North America Adeno Associated Virus Production Market Size by Type (2021-2026)
- 7.2.2 North America Adeno Associated Virus Production Market Size by Type (2027-2032)
- 7.2.3 North America Adeno Associated Virus Production Market Share by Type (2021-2032)
- 7.3 North America Adeno Associated Virus Production Market Size by Application
- 7.3.1 North America Adeno Associated Virus Production Market Size by Application (2021-2026)
- 7.3.2 North America Adeno Associated Virus Production Market Size by Application (2027-2032)
- 7.3.3 North America Adeno Associated Virus Production Market Share by Application (2021-2032)
- 7.4 North America Adeno Associated Virus Production Market Size by Country
- 7.4.1 North America Adeno Associated Virus Production Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Adeno Associated Virus Production Market Size by Country (2021-2026)
- 7.4.3 North America Adeno Associated Virus Production Market Size by Country (2027-2032)
- 7.4.4 North America Adeno Associated Virus Production Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Adeno Associated Virus Production Market Size (2021-2032)
- 8.2 Europe Adeno Associated Virus Production Market Size by Type
- 8.2.1 Europe Adeno Associated Virus Production Market Size by Type (2021-2026)
- 8.2.2 Europe Adeno Associated Virus Production Market Size by Type (2027-2032)
- 8.2.3 Europe Adeno Associated Virus Production Market Share by Type (2021-2032)
- 8.3 Europe Adeno Associated Virus Production Market Size by Application
- 8.3.1 Europe Adeno Associated Virus Production Market Size by Application (2021-2026)
- 8.3.2 Europe Adeno Associated Virus Production Market Size by Application (2027-2032)
- 8.3.3 Europe Adeno Associated Virus Production Market Share by Application (2021-2032)
- 8.4 Europe Adeno Associated Virus Production Market Size by Country
- 8.4.1 Europe Adeno Associated Virus Production Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Adeno Associated Virus Production Market Size by Country (2021-2026)
- 8.4.3 Europe Adeno Associated Virus Production Market Size by Country (2027-2032)
- 8.4.4 Europe Adeno Associated Virus Production Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Adeno Associated Virus Production Market Size (2021-2032)
- 9.2 China Adeno Associated Virus Production Market Size by Type
- 9.2.1 China Adeno Associated Virus Production Market Size by Type (2021-2026)
- 9.2.2 China Adeno Associated Virus Production Market Size by Type (2027-2032)
- 9.2.3 China Adeno Associated Virus Production Market Share by Type (2021-2032)
- 9.3 China Adeno Associated Virus Production Market Size by Application
- 9.3.1 China Adeno Associated Virus Production Market Size by Application (2021-2026)
- 9.3.2 China Adeno Associated Virus Production Market Size by Application (2027-2032)
- 9.3.3 China Adeno Associated Virus Production Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Adeno Associated Virus Production Market Size (2021-2032)
- 10.2 Asia Adeno Associated Virus Production Market Size by Type
- 10.2.1 Asia Adeno Associated Virus Production Market Size by Type (2021-2026)
- 10.2.2 Asia Adeno Associated Virus Production Market Size by Type (2027-2032)
- 10.2.3 Asia Adeno Associated Virus Production Market Share by Type (2021-2032)
- 10.3 Asia Adeno Associated Virus Production Market Size by Application
- 10.3.1 Asia Adeno Associated Virus Production Market Size by Application (2021-2026)
- 10.3.2 Asia Adeno Associated Virus Production Market Size by Application (2027-2032)
- 10.3.3 Asia Adeno Associated Virus Production Market Share by Application (2021-2032)
- 10.4 Asia Adeno Associated Virus Production Market Size by Country
- 10.4.1 Asia Adeno Associated Virus Production Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Adeno Associated Virus Production Market Size by Country (2021-2026)
- 10.4.3 Asia Adeno Associated Virus Production Market Size by Country (2027-2032)
- 10.4.4 Asia Adeno Associated Virus Production Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Adeno Associated Virus Production Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Type
- 11.2.1 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Adeno Associated Virus Production Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Application
- 11.3.1 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Adeno Associated Virus Production Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Country
- 11.4.1 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Adeno Associated Virus Production Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Adeno Associated Virus Production Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst